Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fowler

Showing results (371-380 of 398) with videos related to

Pageof 40
Sort By:
Leukemia & Lymphoma|May 10, 2017
Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma<sup/>Jennifer C Ho, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Cancer Discovery|March 26, 2026
Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid TumorsBurak Uzunparmak, Fei Su, Amber Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host DiseaseJennifer N Brudno, Robert P T Somerville, Victoria Shi, et al.
Blood|February 22, 2013
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantationDaniel H Fowler, Miriam E Mossoba, Seth M Steinberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 25, 2014
Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantationJason M Elinoff, Ulas Bagci, Brad Moriyama, et al.
Cancer|November 20, 2023
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 studyMax J Gordon, Lei Feng, Paolo Strati, et al.
Open Forum Infectious Diseases|August 28, 2025
Usefulness and Limitations of Polymerase Chain Reaction (PCR) for the Diagnosis and Management of Toxoplasmosis Following Allogeneic Hematopoietic Cell Transplant: Single-center Experience With 31 Patients Over 16 YearsMary M Czech, Theresa Jerussi, Sanchita Das, et al.
Blood|May 20, 2017
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphomaMichelle A Fanale, Chan Yoon Cheah, Amy Rich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2018
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single InstitutionRicardo Melendez-Munoz, Rachel Marchalik, Theresa Jerussi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor ResponsesMiriam E Mossoba, David C Halverson, Roger Kurlander, et al.
Pageof 40

Showing results (371-380 of 398) with videos related to

Sort By:
Pageof 40
Leukemia & Lymphoma|May 10, 2017
Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma<sup/>Jennifer C Ho, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Cancer Discovery|March 26, 2026
Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid TumorsBurak Uzunparmak, Fei Su, Amber Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host DiseaseJennifer N Brudno, Robert P T Somerville, Victoria Shi, et al.
Blood|February 22, 2013
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantationDaniel H Fowler, Miriam E Mossoba, Seth M Steinberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 25, 2014
Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantationJason M Elinoff, Ulas Bagci, Brad Moriyama, et al.
Cancer|November 20, 2023
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 studyMax J Gordon, Lei Feng, Paolo Strati, et al.
Open Forum Infectious Diseases|August 28, 2025
Usefulness and Limitations of Polymerase Chain Reaction (PCR) for the Diagnosis and Management of Toxoplasmosis Following Allogeneic Hematopoietic Cell Transplant: Single-center Experience With 31 Patients Over 16 YearsMary M Czech, Theresa Jerussi, Sanchita Das, et al.
Blood|May 20, 2017
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphomaMichelle A Fanale, Chan Yoon Cheah, Amy Rich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2018
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single InstitutionRicardo Melendez-Munoz, Rachel Marchalik, Theresa Jerussi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor ResponsesMiriam E Mossoba, David C Halverson, Roger Kurlander, et al.
Pageof 40